Universal Flu Vaccine Shows 95% Efficacy in Phase 3 Clinical Trials
A single-shot vaccine targeting conserved influenza proteins provides broad protection against all known flu strains, potentially ending seasonal vaccination.
Dr. Catherine Adams·Dec 20, 2025·8 min